1. Home
  2. NLSP vs TCI Comparison

NLSP vs TCI Comparison

Compare NLSP & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • TCI
  • Stock Information
  • Founded
  • NLSP 2015
  • TCI 1983
  • Country
  • NLSP Switzerland
  • TCI United States
  • Employees
  • NLSP N/A
  • TCI N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • TCI Real Estate
  • Sector
  • NLSP Health Care
  • TCI Finance
  • Exchange
  • NLSP Nasdaq
  • TCI Nasdaq
  • Market Cap
  • NLSP 243.8M
  • TCI 239.2M
  • IPO Year
  • NLSP 2021
  • TCI N/A
  • Fundamental
  • Price
  • NLSP $4.45
  • TCI $27.52
  • Analyst Decision
  • NLSP
  • TCI
  • Analyst Count
  • NLSP 0
  • TCI 0
  • Target Price
  • NLSP N/A
  • TCI N/A
  • AVG Volume (30 Days)
  • NLSP 32.7K
  • TCI 2.9K
  • Earning Date
  • NLSP 10-18-2024
  • TCI 11-07-2024
  • Dividend Yield
  • NLSP N/A
  • TCI N/A
  • EPS Growth
  • NLSP N/A
  • TCI N/A
  • EPS
  • NLSP N/A
  • TCI 0.69
  • Revenue
  • NLSP N/A
  • TCI $50,541,000.00
  • Revenue This Year
  • NLSP N/A
  • TCI N/A
  • Revenue Next Year
  • NLSP N/A
  • TCI N/A
  • P/E Ratio
  • NLSP N/A
  • TCI $40.92
  • Revenue Growth
  • NLSP N/A
  • TCI N/A
  • 52 Week Low
  • NLSP $4.08
  • TCI $26.91
  • 52 Week High
  • NLSP $35.60
  • TCI $43.40
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 36.17
  • TCI 41.66
  • Support Level
  • NLSP $4.72
  • TCI $27.38
  • Resistance Level
  • NLSP $5.36
  • TCI $28.36
  • Average True Range (ATR)
  • NLSP 0.56
  • TCI 0.57
  • MACD
  • NLSP -0.01
  • TCI -0.04
  • Stochastic Oscillator
  • NLSP 19.79
  • TCI 32.32

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: